Pacira BioSciences (PCRX) EBT Margin (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly EBT Margin of 2.82% for Q1 2026, down 234.0% year-over-year from 2.1% in Q1 2025, and up 871.52% quarter-over-quarter from 0.29% in Q4 2025.
Pacira BioSciences (PCRX) EBT Margin (2010 - 2026) Analysis & Trends
Pacira BioSciences' EBT Margin history runs 17 years deep, the most recent figure standing at 2.82% for Q1 2026.
- In Q1 2026, EBT Margin fell 234.0% year-over-year to 2.82%; the TTM figure through Mar 2026 stood at 1.79% (up 1147.0% YoY), while the FY2025 annual figure was 2.32%, up 1133.0% from the prior year.
- EBT Margin for Q1 2026 stood at 2.82%, up from 0.29% in the prior quarter.
- The five-year high for EBT Margin was 22.34% in Q2 2023, with the low at 82.37% in Q3 2024.
- The 5-year median for EBT Margin is 5.15% (2025), against an average of 1.74%.
- The sharpest annual moves came in 2024 and 2025: EBT Margin sank 9250 bps in 2024, then jumped 8768 bps in 2025.
- Pacira BioSciences' EBT Margin stood at 3.67% in 2022, then surged by 407 bps to 18.6% in 2023, then retreated by 27 bps to 13.63% in 2024, then tumbled by 98 bps to 0.29% in 2025, then soared by 872 bps to 2.82% in 2026.
- Business Quant data shows PCRX's EBT Margin at 2.82% in Q1 2026, 0.29% in Q4 2025, and 5.31% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Pacira BioSciences | 945.51 Mn | 694.48 Mn | 148.24 Mn | 1.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.33% |
| Mar 31, 2026 | 2.82% |
| Dec 31, 2025 | 0.29% |
| Sep 30, 2025 | 5.31% |
| Jun 30, 2025 | -1.06% |
| Mar 31, 2025 | 5.15% |
| Dec 31, 2024 | 13.63% |
| Sep 30, 2024 | -82.37% |
| Jun 30, 2024 | 20.55% |
| Mar 31, 2024 | 8.16% |
| Dec 31, 2023 | 18.60% |
| Sep 30, 2023 | 10.13% |
| Jun 30, 2023 | 22.34% |
| Mar 31, 2023 | -16.51% |
| Dec 31, 2022 | 3.67% |
| Sep 30, 2022 | 1.24% |
| Jun 30, 2022 | 12.99% |
| Mar 31, 2022 | 4.62% |
| Dec 31, 2021 | -3.89% |
| Sep 30, 2021 | 18.97% |